Equities

Qatari German Company for Medical Devices QPSC

  • Add to watchlist
  • Add to portfolio
  • Add an alert
QGMD:DSM

Qatari German Company for Medical Devices QPSC

Actions
Health CareMedical Equipment and Services
  • Price (QAR)1.49
  • Today's Change-0.024 / -1.58%
  • Shares traded5.00m
  • 1 Year change+10.60%
  • Beta0.7695
Data delayed at least 15 minutes, as of Feb 17 2026 10:13 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Qatari German Company for Medical Devices QPSC is a Qatar-based manufacturer of medical devices. The Company is engaged in the manufacture of single use disposable syringes and trading in medical equipment, tools and supplies. Its product portfolio includes Q JectUltra, an insulin syringe used in diabetic care; Q Flow, specially designed for infusion therapy; Q Need, a single-use hypodermic needle; Q Ject, a single-use syringe specifically intended for administering curative medications; Q Safe, a syringe designed to prevent reuse, enhancing patient safety, among others.

  • Revenue in QAR (TTM)3.73m
  • Net income in QAR-62.68m
  • Incorporated2000
  • Employees6.00
  • Location
    Qatari German Company for Medical Devices QPSCQG Medical Devices, 22556PO BoxDOHA QatarQAT
  • Phone+974 44581201
  • Fax+974 44581328
  • Websitehttps://www.qgmd.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
BioLight Life Sciences Ltd24.85k-16.62m35.29m4.00--0.7906--1,420.47-2.95-2.950.00444.170.0006--0.027---47.82-21.57-52.72-22.97-----86,261.91-13,619.35---2.740.0051--85.59-5.9172.55---0.6994--
Allmed Solutions Ltd0.00-14.63m44.38m22.00--1.12-----0.1328-0.13280.000.33620.00----0.00-28.18-9.16-31.98-10.12--55.39---170.44---25.090.0139-------715.47--8.08--
Nissan Medical Industries Ltd758.07m1.18k106.37m406.00--0.44993.170.1403-0.0088-0.008872.7322.000.92964.127.141,578,126.00-0.03613.80-0.07927.1111.3618.52-0.03893.900.49170.89170.3751---9.521.8739.95-12.83-9.20--
Pulsenmore Ltd11.02m-52.06m128.18m63.00--1.41--11.64-6.86-6.861.4511.810.0660.24722.23147,777.80-31.20-23.53-34.52-25.3237.36---472.58-555.166.44-32.440.2476--56.12--37.28--23.66--
Qatari German Co for Medical Device QPSC3.73m-62.68m175.10m6.00------46.88-0.5427-0.54270.0323-0.23780.02210.24880.1407---37.10-7.00-79.98-12.82-33.5929.16-1,678.24-43.840.1270-5.001.24---64.154.12-5,226.27---15.71--
Epitomee Medical Ltd0.001.19m307.61m42.00252.462.7282.18--0.03420.03420.003.180.00----0.000.9033-18.000.9604-18.81-------372.227.65--0.1275---100.00--74.23--107.15--
Data as of Feb 17 2026. Currency figures normalised to Qatari German Company for Medical Devices QPSC's reporting currency: QAR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.